BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25257577)

  • 1. Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow-up.
    Ehdaivand S; Simon RA; Sung CJ; Steinhoff MM; Lawrence WD; Quddus MR
    Hum Pathol; 2014 Nov; 45(11):2311-7. PubMed ID: 25257577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental power morcellation of malignancy: a retrospective cohort study.
    Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
    Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
    Tan A; Salfinger S; Tan J; Cohen P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
    Mowers EL; Skinner B; McLean K; Reynolds RK
    J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial dye instillation: a novel approach to histopathologic evaluation of morcellated hysterectomy specimens.
    Tam T; Harkins G; Caldwell T; Zaino R; Hazard D
    J Minim Invasive Gynecol; 2013; 20(5):667-71. PubMed ID: 23714746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of occult malignancy in morcellated hysterectomy: a case series.
    Hagemann IS; Hagemann AR; LiVolsi VA; Montone KT; Chu CS
    Int J Gynecol Pathol; 2011 Sep; 30(5):476-83. PubMed ID: 21804400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Manual Morcellation After Vaginal or Laparoscopic-assisted Vaginal Hysterectomy.
    Balgobin S; Maldonado PA; Chin K; Schaffer JI; Hamid CA
    J Minim Invasive Gynecol; 2016; 23(4):542-7. PubMed ID: 26802908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
    Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
    Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine morcellation and survival in uterine sarcomas.
    Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
    Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Occult Malignancy Within Morcellated Specimens Removed During Laparoscopic Sacrocolpopexy.
    Vallabh-Patel V; Saiz C; Salamon C; Francis A; Pagnillo J; Culligan P
    Female Pelvic Med Reconstr Surg; 2016; 22(4):190-3. PubMed ID: 26945272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms.
    Seidman MA; Oduyebo T; Muto MG; Crum CP; Nucci MR; Quade BJ
    PLoS One; 2012; 7(11):e50058. PubMed ID: 23189178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
    Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
    Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Grade Endometrial Stromal Sarcoma Diagnosed 8 Years After Hysterectomy With Morcellation.
    Sanneh A; Murdock T; Wethington SL; Fader AN; Xing D; Beavis AL
    Obstet Gynecol; 2020 Aug; 136(2):365-368. PubMed ID: 32649495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
    George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
    Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morcellating uterine mesenchymal tumors: The pathologist's view.
    Pavlakis K; Messini I; Yiannou P; Gavresea T; Chrysanthakis D; Hilaris G; Panoskaltsis T
    J Obstet Gynaecol Res; 2017 Mar; 43(3):580-586. PubMed ID: 28120430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsuspected Uterine Sarcoma in an Urban Hospital: Does Surgical Approach Matter?
    DiNapoli MN; Truong MD; Halfon JK; Burke WM
    J Minim Invasive Gynecol; 2018; 25(3):491-497. PubMed ID: 29061369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation.
    Rivard C; Salhadar A; Kenton K
    J Minim Invasive Gynecol; 2012; 19(3):313-6. PubMed ID: 22417903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
    Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
    Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
    Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
    Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.